Editor's Note A September 2024 study, published in the Journal of the American College of Cardiology, found that subclinical atherosclerosis progression in asymptomatic individuals is strongly linked to increased risk of death from any cause, CathLab Digest September 30 reports. The study, led by Mount Sinai Fuster Heart Hospital researchers,…
Editor's Note A recent study in JAMA Surgery showed women with hepatocellular carcinoma (HCC) were 8% less likely than men to receive a liver transplant and 6% more likely to die or be removed from the waitlist, Healio reported September 9. The study, which analyzed 31,725 adults waitlisted for…
Editor's Note A recent study from two tertiary care centers highlighted significant sex differences in long-term outcomes after cardiac surgery, especially concerning postoperative atrial fibrillation (postopAF), MedPage August 21 reports. The study, published in JAMA Network, found that while women were less likely than men to develop postopAF following a…
Editor's Note Clinicians managing surgical patients on direct oral anticoagulants (DOACs) should adopt a different approach depending on the procedure, according to research published August 12 in JAMA Network. Used to treat patients with atrial fibrillation and venous thromboembolism, DOACs must be managed effectively to minimize risks of bleeding, researchers…
Editor's Note The “surgical pause”—a means of validating whether surgery is truly safe for patients deemed to be “frail” before starting a procedure—significantly reduces mortality rates and is changing practices at more than 50 Veterans Administration (VA) hospitals, the Pittsburgh Post-Gazette reported August 18. Developed by VA surgeons Daniel Hall…
Editor's Note A recent study conducted across 185 hospital wards in England highlights the significant impact of nurse staffing levels and staff composition on patient mortality. Published August 19 in JAMA, the study analyzed data from over 626,000 hospital admissions between 2015 and 2020. It found that low staffing levels…
Editor's Note The US Food and Drug Administration has announced class 1 recalls—the most severe category indicating risk of serious injury or death—for Abbot Medical’s HeartMate System Monitor and Philips Respironics OmniLab Advanced+ (OLA+) ventilator. According to the agency’s June 28 report, the recall of the HeartMate System Monitor, part…
Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…
Editor's Note Building on previous evidence favoring thrombectomy even in high-risk cases, the prospective randomized LASTE trial finds the surgical procedure could reduce mortality and improve funcational outcomes in patients with acute stroke and large infarct of unrestricted size. Medpage Today reported the news May 8. Originally published in the…
Editor's Note Sexual orientation has a significant impact on all-cause mortality rates among female nurses, according to a study published April 25 in Jama. The prospective cohort study focused on 90,833 women initially recruited in 1989 for Nurses’ Health Study II whose sexual orientation had been identified in 1995. Of…